ImmunityBio received prior approval in the U.S. on July 8, 2025, and Patrick Soon-Shiong was noted as Founder and Executive Chairman.
1 report, 0 independent
Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ImmunityBio received prior approval in the U.S. on July 8, 2025, and Patrick Soon-Shiong was noted as Founder and Executive Chairman.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ImmunityBio
biotech company
Nothing else this week.
-
Patrick Soon-Shiong
Chinese-American billionaire physician, CEO & philanthropist
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet